Retatrutide Study Evaluates Impact on Obesity and Cardiovascular Disease | Retatrutide News

A study on retatrutide for obesity and cardiovascular disease has been completed. It assessed the drug's efficacy and safety over 113 weeks.
Clinical Trials · October 17, 2026